Many of those European pharma companies do most of their work and make most of their money in the US.
While it's true that the exposure of top European firms can be often 50%+ of total revenue from U.S, that:
- Doesn't make them non viable without the American market, just less rich.
- Doesn't reflect the 5 to 10 times higher price Americans pay for the same drugs.
You can have a healthy industries with plenty of billions to be around and have decently priced drugs.
What you get in the US is uber profitable industries and people scrapping around.
alt Hacker News
While it's true that the exposure of top European firms can be often 50%+ of total revenue from U.S, that:
- Doesn't make them non viable without the American market, just less rich.
- Doesn't reflect the 5 to 10 times higher price Americans pay for the same drugs.
You can have a healthy industries with plenty of billions to be around and have decently priced drugs.
What you get in the US is uber profitable industries and people scrapping around.